Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies
Abstract NK‐cell reactivity against cancer is conceivably suppressed in the tumor microenvironment by the interaction of the inhibitory receptor NKG2A with the non‐classical MHC‐I molecules HLA‐E in humans or Qa‐1b in mice. We found that intratumoral delivery of NK cells attains significant therapeu...
Saved in:
| Main Authors: | Ignacio Melero, Maria C Ochoa, Carmen Molina, Sandra Sanchez‐Gregorio, Saray Garasa, Carlos Luri‐Rey, Sandra Hervas‐Stubbs, Noelia Casares, Edurne Elizalde, Gabriel Gomis, Assunta Cirella, Pedro Berraondo, Alvaro Teijeira, Maite Alvarez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2023-10-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202317804 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic
by: Maite Alvarez, et al.
Published: (2023-12-01) -
Repurposing the yellow fever vaccine for intratumoral immunotherapy
by: Maria Angela Aznar, et al.
Published: (2019-11-01) -
A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer
by: Elitsa Boneva, et al.
Published: (2025-03-01) -
The role of selected NKG2DLs such as MICA, MICB and ULBP4 as potential markers in multiple sclerosis
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-07-01) -
POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
by: E. A. Shulenina, et al.
Published: (2017-08-01)